Trials / Terminated
TerminatedNCT00600093
Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether administrating of Amantadine (a dopamine agonist) to patients suffering from Parkinson disease during the perioperative period is safe, and to asses potential benefits of this treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amantadine | IV Amantadine 200mg \*1/d at the beginning of surgery and 24 hours following surgery |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2008-01-24
- Last updated
- 2011-07-26
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00600093. Inclusion in this directory is not an endorsement.